Novartis Ag (NVSEF) EBIT Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) EBIT Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 15.64%
Jun 30, 2024 8.55%
Dec 31, 2023 87.04%
Jun 30, 2023 2.48%
Mar 31, 2023 -4.85%
Dec 31, 2022 -2.19%
Sep 30, 2022 -0.68%
Jun 30, 2022 -0.46%
Mar 31, 2022 2.81%
Dec 31, 2021 -44.80%
Sep 30, 2021 4.45%
Jun 30, 2021 55.72%
Mar 31, 2021 1,452.44%
Dec 31, 2020 11.49%
Sep 30, 2020 25,108.85%
Jun 30, 2020 2,324.08%
Mar 31, 2020 -957.66%
Jun 30, 2019 2,141.15%
Mar 31, 2019 1,222.82%
Dec 31, 2018 1,437.33%